Translate

Κυριακή 3 Μαΐου 2020

,


[ASAP] Temporal-Spatial-Color Multiresolved Chemiluminescence Imaging for Multiplex Immunoassays Using a Smartphone Coupled with Microfluidic Chip
Analytical ChemistryDOI: 10.1021/acs.analchem.0c01405
Analytical Chemistry
Fri May 01, 2020 07:00
[ASAP] Intuitive Model of Surface Modification Induced by Cluster Ion Beams
Analytical ChemistryDOI: 10.1021/acs.analchem.0c01219
Analytical Chemistry
Fri May 01, 2020 07:00
[ASAP] Bifunctional Au@Pt/Au core@shell Nanoparticles As Novel Electrocatalytic Tags in Immunosensing: Application for Alzheimer’s Disease Biomarker Detection
Analytical ChemistryDOI: 10.1021/acs.analchem.0c00760
Analytical Chemistry
Fri May 01, 2020 07:00
[ASAP] Advanced Liquid Chromatography of Polyolefins Using Simultaneous Solvent and Temperature Gradients
Analytical ChemistryDOI: 10.1021/acs.analchem.0c01095
Analytical Chemistry
Fri May 01, 2020 07:00
[ASAP] Hollow Fiber Liquid-Phase Microextraction At-Line Coupled to Capillary Electrophoresis for Direct Analysis of Human Body Fluids
Analytical ChemistryDOI: 10.1021/acs.analchem.0c00697
Analytical Chemistry
Fri May 01, 2020 07:00
[ASAP] “Sample-to-Answer” Detection of Rare ctDNA Mutation from 2 mL Plasma with a Fully Integrated DNA Extraction and Digital Droplet PCR Microdevice for Liquid Biopsy
Analytical ChemistryDOI: 10.1021/acs.analchem.0c00818
Analytical Chemistry
Thu Apr 30, 2020 07:00
[ASAP] Microfluidic Platform for the Isolation of Cancer-Cell Subpopulations Based on Single-Cell Glycolysis
Analytical ChemistryDOI: 10.1021/acs.analchem.9b05738
Analytical Chemistry
Thu Apr 30, 2020 07:00
[ASAP] One-Step Surface Modification to Graft DNA Codes on Paper: The Method, Mechanism, and Its Application
Analytical ChemistryDOI: 10.1021/acs.analchem.0c00317
Analytical Chemistry
Thu Apr 30, 2020 07:00
[ASAP] Substrate-Photocaged Enzymatic Fluorogenic Probe Enabling Sequential Activation for Light-Controllable Monitoring of Intracellular Tyrosinase Activity
Analytical ChemistryDOI: 10.1021/acs.analchem.0c00746
Analytical Chemistry
Thu Apr 30, 2020 07:00
[ASAP] ICBM-OCEAN: Processing Ultrahigh-Resolution Mass Spectrometry Data of Complex Molecular Mixtures
Analytical ChemistryDOI: 10.1021/acs.analchem.9b05659
Analytical Chemistry
Thu Apr 30, 2020 07:00
[ASAP] Plasmonic Enhanced Gold Nanoclusters-Based Photoelectrochemical Biosensor for Sensitive Alkaline Phosphatase Activity Analysis
Analytical ChemistryDOI: 10.1021/acs.analchem.9b05432
Analytical Chemistry
Thu Apr 30, 2020 07:00
[ASAP] Poly-e-caprolactone Nanofibrous Polymers: A Simple Alternative to Restricted Access Media for Extraction of Small Molecules from Biological Matrixes
Analytical ChemistryDOI: 10.1021/acs.analchem.0c00544
Analytical Chemistry
Thu Apr 30, 2020 07:00
Shedding light: a phylotranscriptomic perspective illuminates the origin of photosymbiosis in marine bivalves
Photosymbiotic associations between metazoan hosts and photosynthetic dinoflagellates are crucial to the trophic and structural integrity of many marine ecosystems, including coral reefs. Although extensive ef...
Most Recent Articles: BMC Evolutionary Biology
Fri May 01, 2020 03:00
The genetic basis of hybrid male sterility in sympatric Primulina species
Sympatric sister species provide an opportunity to investigate the genetic mechanisms and evolutionary forces that maintain species boundaries. The persistence of morphologically and genetically distinct popul...
Most Recent Articles: BMC Evolutionary Biology
Wed Apr 29, 2020 03:00
The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro
The reversion-inducing cysteine-rich protein with kazal motifs (RECK) gene was described as a tumor suppressor gene two decades ago. Recently, novel alternatively spliced products of this gene have been identified. Of these, the transcript variant 3 (RECKVar3) was shown to display tumor-facilitating effects in astrocytoma cells in vitro, with a higher RECKVar3/canonical RECK expression ratio being correlated with lower survival rates of patients. However, the regulatory mechanisms through which the...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma
In patients with metastatic cancer, gut microbiome composition differs between responder and non-responders to immune checkpoint inhibitors. However, there is little consensus on the microbiome taxa associated with response or lack of response. Additionally, recognized confounders of gut microbiome composition have generally not been taken into account. In this study, metagenomic shotgun sequencing was performed on freshly frozen pre-treatment stool samples from 25 patients (12 responders and 13...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Very late recurrence of iris melanoma: 45 years after treatment
Iris melanoma is a rare tumour that accounts for ~3–4% of all uveal melanoma cases. In the past, surgical resection was the sole treatement option, whereas nowadays, it has been replaced by brachytherapy as treatment of choice. Surgical resection is still in use in selected cases but combined with adjuvant radiotherapy in cases of incomplete resection. Herein, we report the case of a very late recurrence, 45 years after surgical resection. A literature review was performed to detect the latest recurrence...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants
Individuals with multiple primary melanomas have rates of germline CDKN2A pathogenic variants of 3%–18%, and are also frequent carriers of variants in the melanocortin-1 receptor. Few patients with numerous (≥3) primary melanomas have been studied with respect to these or other potential germline pathogenic variants. We investigated 46 patients with ≥3 primary melanomas (3, n = 17; 4, n = 14; 5–14, n = 15) to determine if higher rates of germline pathogenic variants of CDKN2A, MC1R, or other cancer...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Epidemiology of cutaneous melanoma and melanoma in situ: a 10-year nationwide retrospective cohort study in South Korea
Numerous studies on the epidemiology of cutaneous melanoma (CM) have been reported for Caucasians, but rarely for Asian populations including Korea. The aim of this study was to investigate the epidemiology of CM and melanoma in situ (MIS) in the Korean population. We investigated a nationally representative sample cohort of over one million Koreans for patients diagnosed with CM and MIS. Annual and overall incidence rates, as well as the survival rate of CM during the study period (2004–2013), were...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)
Approximately, 50% of patients with uveal melanoma develop distant metastasis for which no standard therapy is established. In contrast to cutaneous melanoma, the anti-CTLA-4 antibody ipilimumab showed no clinical activity in uveal melanoma. Liver directed therapies improve local control, but fail to show overall survival (OS) benefit. Preclinical experiments demonstrated that radiofrequency ablation (RFA) induced durable responses in combination with anti-CTLA-4. The aim of this phase Ib/II study...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Induced sarcoid-like reactions in patients with metastatic melanoma treated with dabrafenib and trametinib: a monocentric retrospective study
Combined BRAF and MEK inhibition is one of the first-line treatment strategies for patients with advanced BRAF-mutant melanoma. Sarcoid-like reactions (SLRs) have occasionally been described with melanoma systemic treatments such as immunotherapy or the BRAF inhibitor vemurafenib, but very few cases have been reported with dabrafenib and trametinib. Our aim was to better characterize SLR induced by this combination. We conducted a monocentric retrospective observational study among patients treated...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)
In clinical trials, dabrafenib plus trametinib improved overall survival (OS) compared with single-agent BRAF inhibitors (BRAFi) in patients with BRAF V600-mutant unresectable or metastatic melanoma. We investigated dabrafenib plus trametinib therapy in a compassionate-use setting [Named Patient Program (NPP); DESCRIBE II]. A retrospective chart review of patients with BRAF V600-mutated unresectable stage III/IV melanoma receiving dabrafenib plus trametinib as compassionate use was conducted. Treatment...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
A meta-analysis of melanoma risk in industrial workers
Industrial workers are exposed to occupational pollutants, which may cause diseases such as cancer, but links to melanoma are not established. The identification of industry-related risk factors for melanoma incidence and mortality might be of importance for workers, health providers, and insurance companies. To assess melanoma incidence and mortality among oil/petroleum, chemical, and electrical industry workers. All studies reporting standardized mortality ratios (SMR) and/or standardized incidence...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Validation of dabrafenib-trametinib prognostic groups in patients treated with vemurafenib and cobimetinib for advanced BRAF-mutated melanoma
Prognostic groups defined by lactate dehydrogenase concentration and number of organ sites containing metastases have been reported for patients treated with dabrafenib and trametinib for advanced melanoma. We aimed to validate these prognostic groups for patients treated with vemurafenib and cobimetinib in the coBRIM and BRIM-3 clinical studies. Eight hundred nine patients were included, 240 treated with vemurafenib plus cobimetinib and 569 with vemurafenib. For patients treated with vemurafenib...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Nonhomologous end-joining repair is likely involved in the repair of double-stranded DNA breaks induced by riluzole in melanoma cells
Our group described the oncogenic potential of a normal neuronal receptor, metabotropic glutamate receptor 1 (GRM1/mGluR1, gene/protein), when aberrantly expressed in melanocytes led to cell transformation in vitro and spontaneous metastatic tumors in vivo. Earlier, we demonstrated the accumulation of phosphorylated histone H2AX (γH2AX), a marker for DNA damage when mGluR1-expressing melanoma cells were treated with a functional inhibitor, riluzole. The precise mechanisms on how riluzole induces...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas
The aim of this study was to evaluate metastatic latency and survival after the occurrence of metastases in patients with choroidal/ciliary body melanoma treated with proton therapy. This was a retrospective cohort study. All consecutive patients with choroidal/ciliary body melanoma treated with proton therapy between 1991 and 2010 were included. Overall survival, specific survival (SS), local recurrence-free interval, and metastasis-free interval (MFI) were calculated. There were 508 patients. The...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature
Checkpoint inhibitor immunotherapy is a transformative treatment for advanced malignancies, but can be associated with numerous immune-related adverse events (irAEs). The majority of irAEs include those that closely resemble known cutaneous and neurocutaneous autoimmune or autoinflammatory diseases, such as scleroderma, psoriasis, and dermatomyositis. We present the case of a 63-year-old man with metastatic melanoma undergoing treatment with nivolumab who developed significant motor weakness, paresthesias...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Stage-specific incidence trends of melanoma in an English region, 1996–2015: longitudinal analyses of population-based data
The aim of this study was to examine temporal trends in overall and stage-specific incidence of melanoma. Using population-based data on patients diagnosed with melanoma in East Anglia, England, 1996–2015, we estimated age-standardized time trends in annual incidence rates for each stage at diagnosis. Negative binomial regression was used to model trends over time adjusted for sex, age group and deprivation, and to subsequently examine variation in stage-specific trends by sex and age group. The...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
The successful use of pembrolizumab in a renal transplant recipient with metastatic melanoma
We report a case in which a renal transplant recipient with metastatic melanoma had an excellent response to treatment with second line programmed cell death protein 1 (PD-1) inhibitor therapy, pembrolizumab. Acute cellular allograft rejection on initiation of PD-1 inhibitor was successfully reversed with methylprednisolone. By converting the patient to sirolimus and giving predose prednisolone, pembrolizumab was continued with stable renal function and an excellent oncological response. This case...
Melanoma Research - Current Issue
Sat May 02, 2020 00:43
Physician Burnout, Interrupted
Before the onset of the Covid-19 pandemic, each day seemed to bring another headline about the crisis of physician burnout. The issue had been simmering for years and was brought to a boil by mounting changes in the health care system, most prominently the widespread implementation of the…
The New England Journal of Medicine: Search Results in Health Policy and Reform
Fri May 01, 2020 03:00
Early Detection of Covid-19 through a Citywide Pandemic Surveillance Platform
To the Editor: Traditional approaches to respiratory virus surveillance may not identify novel pathogens in time to implement crucial public health interventions. The Seattle Flu Study is a multi-institutional, community-wide pandemic surveillance platform that was established in November 2018.…
The New England Journal of Medicine: Search Results in Health Policy and Reform
Fri May 01, 2020 03:00
Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic
On March 11, 2020, the World Health Organization designated "coronavirus disease 2019" (Covid-19) a global pandemic. As the number of cases in the United States continues to grow, political leaders are encouraging physical (or "social") distancing to slow the rate of transmission. The goal of this…
The New England Journal of Medicine: Search Results in Health Policy and Reform
Thu Apr 30, 2020 03:00
Feeding Low-Income Children during the Covid-19 Pandemic
As Covid-19 spreads throughout the United States, schools and child care facilities are balancing their role of helping to prevent disease transmission with ensuring access to food for children who rely on the federal nutrition safety net. Together, the U.S. Department of Agriculture (USDA)…
The New England Journal of Medicine: Search Results in Health Policy and Reform
Thu Apr 30, 2020 03:00
Association between Mental Disorders and Subsequent Medical Conditions
Persons with mental disorders are at increased risk for other types of mental disorders and for a range of general medical conditions. These medical conditions contribute to a decreased quality of life, increased health care utilization, and premature death in many persons with mental disorders.…
The New England Journal of Medicine: Search Results in Health Policy and Reform
Thu Apr 30, 2020 03:00
Social Isolation, Loneliness, and Hearing Loss During COVID-19
No abstract available
The Hearing Journal - Current Issue
Fri May 01, 2020 03:00
Research Drives More Accessible, Affordable Hearing Care
No abstract available
The Hearing Journal - Current Issue
Fri May 01, 2020 03:00
2020 Priorities of Aging Baby Boomers
No abstract available
The Hearing Journal - Current Issue
Fri May 01, 2020 03:00
Teleaudiology: Strategies, Considerations During a Crisis and Beyond
No abstract available
The Hearing Journal - Current Issue
Fri May 01, 2020 03:00
Factors Affecting Quality of Life in Adolescent CI Users
No abstract available
The Hearing Journal - Current Issue
Fri May 01, 2020 03:00

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου

Translate